A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

Clinical trial NCT05330325 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05330325
Sponsor: Novo Nordisk A/S
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

SGA, Turner Syndrome, Noonan Syndrome, ISS

Start date: 2022-08-10
Primary completion: 2024-08-05
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.